Barclays’s Kindred Healthcare KND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-4,200
| Closed | -$38K | – | 7683 |
|
|
2018
Q2 | $38K | Sell |
4,200
-8,300
| -66% | -$74.4K | ﹤0.01% | 5820 |
|
|
2018
Q1 | $114K | Buy |
12,500
+4,200
| +51% | +$38.9K | ﹤0.01% | 5291 |
|
|
2017
Q4 | $81K | Buy |
8,300
+1,700
| +26% | +$12.6K | ﹤0.01% | 5411 |
|
|
2017
Q3 | $45K | Sell |
6,600
-3,000
| -31% | -$25.5K | ﹤0.01% | 5408 |
|
|
2017
Q2 | $112K | Buy |
9,600
+3,800
| +66% | +$37.5K | ﹤0.01% | 4826 |
|
|
2017
Q1 | $48K | Sell |
5,800
-2,900
| -33% | -$22.7K | ﹤0.01% | 5368 |
|
|
2016
Q4 | $68K | Buy |
8,700
+3,600
| +71% | +$29.5K | ﹤0.01% | 4980 |
|
|
2016
Q3 | $52K | Buy |
5,100
+1,300
| +34% | +$14.4K | ﹤0.01% | 4963 |
|
|
2016
Q2 | $43K | Sell |
3,800
-1,500
| -28% | -$18.8K | ﹤0.01% | 4915 |
|
|
2016
Q1 | $64K | Buy |
5,300
+2,000
| +61% | +$20.7K | ﹤0.01% | 4637 |
|
|
2015
Q4 | $36K | Buy |
+3,300
| New | +$42.7K | ﹤0.01% | 4971 |
|
|
2015
Q3 | – | Sell |
-300
| Closed | -$6K | – | 7213 |
|
|
2015
Q2 | $6K | Sell |
300
-1,200
| -80% | -$27.5K | ﹤0.01% | 6398 |
|
|
2015
Q1 | $35K | Buy |
+1,500
| New | +$30.4K | ﹤0.01% | 5532 |
|
|
2014
Q4 | – | Sell |
-1,300
| Closed | -$25K | – | 7788 |
|
|
2014
Q3 | $25K | Buy |
1,300
+500
| +63% | +$10.9K | ﹤0.01% | 6355 |
|
|
2014
Q2 | $18K | Buy |
800
+200
| +33% | +$4.89K | ﹤0.01% | 6579 |
|
|
2014
Q1 | $14K | Hold |
600
| – | – | ﹤0.01% | 6786 |
|
|
2013
Q4 | $11K | Sell |
600
-2,300
| -79% | -$37.1K | ﹤0.01% | 6980 |
|
|
2013
Q3 | $38K | Buy |
2,900
+800
| +38% | +$11.5K | ﹤0.01% | 6218 |
|
|
2013
Q2 | $28K | Buy |
+2,100
| New | +$25.1K | ﹤0.01% | 6673 |
|
Barclays's KND Position: Q3 2018 in Review
Barclays sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 325,463 shares — an estimated $2.93M sold.
Barclays first reported a position in KND in Q2 2013 and held it in 21 quarters. The position peaked at $5.47M in Q3 2014. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.
- Barclays reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
- Barclays sold 325,463 Kindred Healthcare shares in Q3 2018, an estimated $2.93M.
- Barclays first reported a position in Kindred Healthcare in Q2 2013 and held it in 21 quarters.
- Barclays's Kindred Healthcare position peaked at $5.47M in Q3 2014.
- 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.